Posts Tagged ‘Saville’
Promising results from the PATHFINDER II cancer screening study
Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. At Inova Schar Cancer, we’re excited to share encouraging news from a major national research study called PATHFINDER II. This study is helping shape the future of cancer screening – and it’s bringing…
Read More“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025
While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening…
Read MoreGroundbreaking Inova study finds potential link between long-distance running and colon cancer
Fairfax, VA – A groundbreaking new study led by Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, has revealed a potential link between extreme endurance exercise and increased risk of advanced colon cancer in younger adults, raising new questions about screening for high-performance athletes.…
Read More“Are Marathons and Extreme Running Linked to Colon Cancer?,” New York Times, August 19, 2025
Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured…
Read MoreCan certain foods reduce your risk of getting cancer?
It is difficult to browse the internet or social media, especially in the new year, without coming across the term “superfood.” Surprisingly, this is not a new term. The earliest recorded use of superfood was in the early 20th century by the United Fruit Company in its quest to market bananas. The use of the…
Read MoreLung cancer screening at Saville Center: Less time, less worry for patients
Amit Mahajan, MD is board certified in pulmonary disease and critical care medicine. He serves as the medical director of interventional pulmonology and the complex airways disease program at Inova Fairfax Medical Campus. Lung cancer screening takes time. And that time often turns into stress for patients and their loved ones. That’s one reason that…
Read MoreCancer Prevention Through Nutrition
Marion Biggs, RD, LD, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in nutrition support. Approximately 40 percent of all cancer cases can be attributed to modifiable risk factors. These are risk factors based on habits that are within our control. One large decision we…
Read MoreDon’t Delay Your Colonoscopy
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. You may have seen last week’s headlines questioning the importance of colonoscopies as a cancer screening test that saves lives. Yes, a recent study of nearly 85,000…
Read MoreInova Saville Cancer Screening and Prevention Center Joins an International Effort to Fight Pancreatic Cancer
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. We know the realities of pancreatic cancer. It is a disease that caused 48,220 deaths in the United States in 2021, and 466,003 worldwide in 2020. It…
Read MoreInova’s Thyroid Nodule Clinic Aims for Seamless, Expedited Care
Jina Kim, MD is a general surgeon and fellowship-trained in endocrine surgery. She is a member of the Inova Endocrine Tumor Program team at Inova Schar Cancer Institute. One message I emphasize when I talk about thyroid cancer is that it is very treatable. The outcome for most patients with papillary and follicular thyroid cancers…
Read More